Study of forced degradation behavior of Eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 4, 2009, Pages 622-629

  Jocić, Biljana ^a   Zečević, Mira ^a   Živanović, Ljiljana ^a   Protić, Ana ^a   Jadranin, Milka ^b   Vajs, Vlatka ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Eletriptan hydrobromide; Forced degradation studies; Multivariate optimization methodology; Stability indicating method

Indexed keywords

ELETRIPTAN; METHANOL; WATER;

ARTICLE; DRUG DECOMPOSITION; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG STABILITY; DRUG STRUCTURE; FLOW RATE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PHOTOLYSIS; PRIORITY JOURNAL; SOLID STATE; TABLET FORMULATION; TEMPERATURE; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, LIQUID; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; LIGHT; MASS SPECTROMETRY; OXIDATION-REDUCTION; PYRROLIDINES; SEROTONIN RECEPTOR AGONISTS; TABLETS; TEMPERATURE; TRYPTAMINES;

EID: 67949117234     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.01.034     Document Type: Article

References (30)

1. Alsante K.M., Ando A., Brown R., Ensing J., Hatajik T.D., Kong W., and Tsuda Y. Adv. Drug Deliv. Rev. 59 (2007) 29-37
2. Bakshi M., and Singh S. J. Pharm. Biomed. Anal. 28 (2002) 1011-1040
3. ICH topic Q1A(R2), Stability testing on new drug substances and products (2003) Fed. Regist. 68: 65717-65718.
4. Hoskin K.L., Lambert G.A., Donaldson C., and Zagami A.S. Brain Res. 998 (2004) 91-99
5. Durham P.L., Dong P.X., Belasco K.T., Kasperski J., Gierasch W.W., Edvinsson L., Heistad D.D., Faraci F.M., and Russo A.F. Brain Res. 997 (2004) 103-110
6. Cooper J.D.H., Muirhead D.C., and Taylor J.E. J. Pharm. Biomed. Anal. 21 (1999) 787-796
7. Zecevic M., Jocic B., Agatonovic-Kustrin S., and Zivanovic Lj. J. Serb. Chem. Soc. 71 (2006) 1195-1205
8. Sagirli O., Onal A., and Sensoy D. Chromatographia 68 (2008) 269-273
9. Nowak M., and Seubert A. J. Chromatogr. A 855 (1999) 91-109
10. Wang Y., Harrison M., and Clark B.J. J. Chromatogr. A 1105 (2006) 199-207
11. Mamani M.C.V., Farfan J.A., Reyes F.G., and Rath S. Talanta 70 (2006) 236-243
12. Wsol V., and Fell A.F. J. Biochem. Biophys. Methods 54 (2002) 377-390
13. Sivakumar T., Manavalan R., Muralidharan C., and Valliappan K. J. Pharm. Biomed. Anal. 43 (2007) 1842-1848
14. Candioti L.V., Robles J., Mantovani V., and Goicoechea H. Talanta 69 (2006) 140-147
15. Rueda M.E., Sarabia L.A., Herrero A., and Ortiz M.C. Anal. Chim. Acta 479 (2003) 173-184
16. Ortiz M.C., Herrero A., Sanllorente S., and Reguera C. Talanta 65 (2005) 246-254
17. Safa F., and Hadjmohammadi M.R. J. Chromatogr. A 1078 (2005) 42-50
18. Bhardwaj S.P., and Singh S. J. Pharm. Biomed. Anal. 46 (2008) 113-120
19. Xu X., Bartlett M.G., and Stewart J.T. J. Pharm. Biomed. Anal. 26 (2001) 367-377
20. Bansal G., Singh M., and Jindal K.C. Chromatographia 66 (2007) 751-755
21. Singh S., Singh B., Bahuguna R., Wadhwa L., and Saxena R. J. Pharm. Biomed. Anal. 41 (2001) 1037-1040
22. Pathare D.B., Jadhan A.S., and Shingare M.S. J. Pharm. Biomed. Anal. 43 (2007) 1825-1830
23. Kumar V., Bhutani H., and Singh S. J. Pharm. Biomed. Anal. 43 (2007) 769-773
24. Burana-osot J., Ungboriboonpisal S., and Sriphong L. J. Pharm. Biomed. Anal. 40 (2006) 1068-1072
25. Dutta A.K., Avery B.A., and Wyandt C.M. J. Chromatogr. A 1110 (2006) 35-45
26. Dunge A., Sharda N., Singh B., and Sing S. J. Pharm. Biomed. Anal. 37 (2005) 1109-1114
27. Joule J.A., Mills K., and Smith G.F. Heterocyclic chemistry. third ed. (1995), Chapman & Hall, London
28. Evants D.C., O'Connor D., Lake B.G., Evers R., Allen C., and Hargreaves R. Drug Metab Dispos. 31 (2003) 861-869
29. Ferreira S.L.C., Brun R.E., Paranhos da Silva E.G., Lopes dos Santos W.N., Quintella C.M., David J.M., Bittencourt de Andrade J., Breitkreitz M.C., Jardim I.C.S.F., and Neto B.B. J. Chromatogr. A 1158 (2007) 2-14
30. ICH topic Q2(R1), Validation of analytical procedures: text and methodology (1997, addendum incorporated 2005) Fed. Regist. 62: 27463-27467.